No Data
No Data
No Data
No Data
No Data
Express News | Kiromic Biopharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients
Moomoo 24/7Apr 24 08:08 ET
Kiromic Biopharma Outlines Vision in Stakeholder Meetings
TipRanksApr 19 16:43 ET
Kiromic BioPharma Files to Withdraw Registration Statement
Seeking AlphaApr 10 17:19 ET
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial
PDF Version Favorable Safety and Tolerability also Observed HOUSTON--(BUSINESS WIRE)--Mar. 19, 2024-- Kiromic BioPharma, Inc. (OTCQB: KRBP) ("Kiromic" or the "Company") reports early efficacy res
Kiromic BioPharmaMar 19 00:00 ET
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
Yahoo FinanceMar 8 08:35 ET
Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024
Yahoo FinanceMar 5 08:35 ET
No Data
No Data